<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PRF</journal-id>
<journal-id journal-id-type="hwp">spprf</journal-id>
<journal-id journal-id-type="nlm-ta">Perfusion</journal-id>
<journal-title>Perfusion</journal-title>
<issn pub-type="ppub">0267-6591</issn>
<issn pub-type="epub">1477-111X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0267659112460075</article-id>
<article-id pub-id-type="publisher-id">10.1177_0267659112460075</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A successful septal ablation of the first septal perforator artery arising from the circumflex artery</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kilicgedik</surname><given-names>A</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Karabay</surname><given-names>CY</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Aung</surname><given-names>SM</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Guler</surname><given-names>A</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Kalayci</surname><given-names>A</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Izgi</surname><given-names>A</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Kirma</surname><given-names>C</given-names></name>
</contrib>
<aff id="aff1-0267659112460075">Cardiology, Koşuyolu Heart &amp; Research Hospital, Cevizli, Kartal, Istanbul, Turkey</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-0267659112460075">Can Yucel Karabay Koşuyolu Heart &amp; Research Hospital Cardiology Clinic, Denizer Street 34846 Cevizli, Kartal İstanbul, Turkey Email: <email>karabaymd@yahoo.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<issue>1</issue>
<fpage>88</fpage>
<lpage>90</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Congenital coronary anomalies are usually incidental, uncommon and asymptomatic. We present a case of a successful septal ablation of the first septal perforator artery arising from the circumflex artery in a patient with symptomatic hypertrophic cardiomyopathy.</p>
</abstract>
<kwd-group>
<kwd>hypertrophic cardiomyopathy</kwd>
<kwd>coronary anomalies</kwd>
<kwd>anomalous septal perforator artery</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0267659112460075" sec-type="intro">
<title>Introduction</title>
<p>Congenital coronary anomalies are usually incidental, uncommon and asymptomatic. The prevalence of coronary artery anomalies in the general population is around 1-2%.<sup><xref ref-type="bibr" rid="bibr1-0267659112460075">1</xref></sup> With the increased use of coronary angiography, coronary anomalies are recognized more frequently and their significance is understood better.<sup><xref ref-type="bibr" rid="bibr2-0267659112460075">2</xref></sup> The anomaly of the first septal perforating artery is rarely described in the literature.<sup><xref ref-type="bibr" rid="bibr3-0267659112460075">3</xref></sup> Catheter-based infarction of the ventricular septum supplied by the first septal perforating artery is applied as a non-surgical method to treat patients with severely symptomatic hypertrophic cardiomyopathy (HCM) as it supplies the portion of the ventricular septum that contributes to sub-aortic stenosis in most of these patients. The thorough knowledge of the size and distribution of this artery is important for performing the procedure.<sup><xref ref-type="bibr" rid="bibr4-0267659112460075">4</xref></sup> We present a case of a successful septal ablation of the first septal perforator artery arising from the circumflex artery in a patient with symptomatic hypertrophic cardiomyopathy.</p>
</sec>
<sec id="section2-0267659112460075" sec-type="cases">
<title>Case Report</title>
<p>An 80- year-old woman was admitted to our hospital with exertional chest pain. During cardiac examination, there was a 3/6 systolic murmur heard at the left parasternal edge. On echocardiography, normal left ventricular systolic functions and a moderate mitral regurgitation were seen. The basal septum thickness was 2.2 cm and a gradient of 11 mmHg at rest and 200 mmHg with a valsalva maneuver were measured at the left ventricular outflow tract (LVOT) (<xref ref-type="fig" rid="fig1-0267659112460075">Figure 1A</xref>). Under medical therapy, she remained symptomatic. Coronary angiography was performed and found to be normal, but the first septal perforator artery was seen arising from the circumflex artery (<xref ref-type="fig" rid="fig1-0267659112460075">Figure 1B</xref> and supplementary video 1 which will appear online with this paper <ext-link ext-link-type="uri" xlink:href="http://prf.sagepub.com">http://prf.sagepub.com</ext-link>), (<xref ref-type="fig" rid="fig1-0267659112460075">Figure 1C</xref> and supplementary video 2 which will appear online with this paper <ext-link ext-link-type="uri" xlink:href="http://prf.sagepub.com">http://prf.sagepub.com</ext-link>). Alcohol septal ablation was planned. After an 8 Fr sheath was inserted into the right femoral artery, the anomalous septal artery was wired with a floppy guidewire using a Judkins left guiding catheter. An over-the-wire balloon was passed through the septal artery and inflated in the proximal portion of the anomalous artery (<xref ref-type="fig" rid="fig1-0267659112460075">Figure 1D</xref>). Agitated serum was infused into the anomalous artery and the basal interventricular septum at the point of mitral valve – septal contact was displayed on echocardiogram. After documentation of the correct trajectory and lack of remote distribution, a dose of 1 cc ethanol was infused. The control angiogram demonstrated complete obliteration of the anomalous septal perforator artery. At the end of the procedure, there was a provocable gradient of 40 mmHg at the LVOT. During the follow-up, the symptoms of the patient regressed and she was discharged without any complication.</p>
<fig id="fig1-0267659112460075" position="float">
<label>Figure 1.</label>
<caption>
<p>(A) An echocardiogram showing the basal septum thickness was 2.2 cm. (B) Right anterior oblique coronary view showing the first septal perforator artery arising from the circumflex artery (white arrow). (C) Left anterior oblique coronary view showing the first septal perforator artery arising from the circumflex artery (dotted white arrow). (D) An over-the-wire balloon was passed through the septal artery and inflated in the proximal portion of the anomalous artery (black arrow).</p>
</caption>
<graphic xlink:href="10.1177_0267659112460075-fig1.tif"/>
</fig>
</sec>
<sec id="section3-0267659112460075" sec-type="discussion">
<title>Discussion</title>
<p>In some patients with hypertrophic cardiomyopathy, symptoms can occur due to dynamic left ventricle outflow obstruction and systolic anterior motion of the mitral valve. Although surgical myotomy or myectomy is the gold standard therapy, percutaneous transluminal septal myocardial ablation (PTSMA: the injection of alcohol into a septal perforator branch perfusing the basal septum) has emerged as an effective alternative treatment option in the past 15 years. This technique aims to reduce the hypertrophied septum by creating a small myocardial infarction, confined to the part of the septum responsible for the formation of the gradient.<sup><xref ref-type="bibr" rid="bibr5-0267659112460075">5</xref></sup></p>
<p>The interventricular septum is considered as the most densely vascularized portion of the heart.<sup><xref ref-type="bibr" rid="bibr6-0267659112460075">6</xref>
<xref ref-type="bibr" rid="bibr7-0267659112460075"/>-<xref ref-type="bibr" rid="bibr8-0267659112460075">8</xref></sup> The anatomy of the septal artery can be highly variable, especially when there is severe hypertrophy.<sup><xref ref-type="bibr" rid="bibr9-0267659112460075">9</xref></sup> Angiographically, the incidence varies from 0.5% to 2.25%.<sup><xref ref-type="bibr" rid="bibr7-0267659112460075">7</xref></sup> The first septal perforator artery normally originates from the left anterior descending artery, but has been reported that the anomalous septal perforator artery can arise from the right coronary artery, the right sinus valsalva, the left main coronary artery, the diagonal artery or the circumflex artery or its obtuse marginal branches.<sup><xref ref-type="bibr" rid="bibr3-0267659112460075">3</xref>,<xref ref-type="bibr" rid="bibr7-0267659112460075">7</xref></sup> The first anterior septal perforator artery is usually the longest (4-6 cm) and the largest, vascularizing a large portion of the interventricular septum as well as the bundle of His and the bundle branches of the conduction system. It often supplies the atrioventricular node.<sup><xref ref-type="bibr" rid="bibr7-0267659112460075">7</xref></sup> It is hard to see the origin of the first septal perforator artery in angiography unless it is selectively opacified. The anomalous septal branch can protect the septum when the proximal left anterior descending artery is obstructed.<sup><xref ref-type="bibr" rid="bibr2-0267659112460075">2</xref></sup></p>
<p>In our case, the septal perforator artery originated from the circumflex artery. The patient was symptomatic under medical therapy and a septal ablation was needed. We have demonstrated that septal ablation can be done safely and effectively without any complications in a patient where that first septal perforator artery originated from the circumflex artery. Previously, a successful septal ablation of the first septal perforator artery arising from right coronary artery was reported by Choi et al.<sup><xref ref-type="bibr" rid="bibr9-0267659112460075">9</xref></sup></p>
<p>To our knowledge, our case is the first describing septal ablation of the first septal perforator artery arising from the circumflex artery, so far. Together with the previously described case,<sup><xref ref-type="bibr" rid="bibr9-0267659112460075">9</xref></sup> our case showed that septal ablation therapy can be performed effectively and safely in patients with hypertrophic cardiomyopathy and septal perforator anomaly.</p>
<p>In patients with hypertrophic cardiomyopathy due to septal hypertrophy, septal vascularization can vary and it is important to pay attention for septal perforator anomalies during angiography. Septal ablation therapy should be considered as an alternative therapy in these patients, even in the presence of an anomalous artery.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
<fn fn-type="conflict">
<label>Conflict of interest statement</label>
<p>The authors have no conflicts of interest to declare</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0267659112460075">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tariq</surname><given-names>R</given-names></name>
<name><surname>Kureshi</surname><given-names>SB</given-names></name>
<name><surname>Siddiqui</surname><given-names>UT</given-names></name>
<name><surname>Ahmed</surname><given-names>R</given-names></name>
</person-group>. <article-title>Congenital anomalies of coronary arteries: diagnosis with 64 slice multidetector CT</article-title>. <source>Eur J Radiol</source> <year>2012</year>; <volume>81</volume>: <fpage>1790</fpage>–<lpage>1797</lpage>.</citation>
</ref>
<ref id="bibr2-0267659112460075">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kimbiris</surname><given-names>D</given-names></name>
<name><surname>Iskandrian</surname><given-names>AS</given-names></name>
<name><surname>Segal</surname><given-names>BL</given-names></name>
<name><surname>Bemis</surname><given-names>CE</given-names></name>
</person-group>. <article-title>Anomalous aortic origin of coronary arteries</article-title>. <source>Circulation</source> <year>1978</year>; <volume>58</volume>: <fpage>606</fpage>–<lpage>615</lpage>.</citation>
</ref>
<ref id="bibr3-0267659112460075">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Palomo</surname><given-names>AR</given-names></name>
<name><surname>Schrager</surname><given-names>BR</given-names></name>
<name><surname>Chahine</surname><given-names>RA</given-names></name>
</person-group>. <article-title>Anomalous separate origin of the septal perforator coronary artery from the left sinus of valsalva</article-title>. <source>Cathet Cardiovasc Diagn</source> <year>1984</year>; <volume>10</volume>: <fpage>385</fpage>–<lpage>388</lpage>.</citation>
</ref>
<ref id="bibr4-0267659112460075">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Singh</surname><given-names>M</given-names></name>
<name><surname>Edwards</surname><given-names>WD</given-names></name>
<name><surname>Holmes</surname><given-names>DR</given-names></name>
<name><surname>Tajil</surname><given-names>AJ</given-names></name>
<name><surname>Nishimura</surname><given-names>RA</given-names></name>
</person-group>. <article-title>Anatomy of the first septal perforating artery: a study with implications for ablation therapy for hypertrophic cardiomyopathy</article-title>. <source>Mayo Clin Proc</source> <year>2001</year>; <volume>76</volume>: <fpage>799</fpage>–<lpage>802</lpage>.</citation>
</ref>
<ref id="bibr5-0267659112460075">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rigopoulos</surname><given-names>AG</given-names></name>
<name><surname>Seggewiss</surname><given-names>H</given-names></name>
</person-group>. <article-title>A decade of percutaneous septal ablation in hypertrophic cardiomyopathy</article-title>. <source>Circ J</source> <year>2010</year>; <volume>75</volume>: <fpage>28</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr6-0267659112460075">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Christiaens</surname><given-names>L</given-names></name>
<name><surname>Ardilouze</surname><given-names>P</given-names></name>
<name><surname>Allal</surname><given-names>J</given-names></name>
</person-group>. <article-title>Anomalous septal artery originating from the right coronary sinus and detection of the interarterial course using multislice computed tomography (MSCT)</article-title>. <source>Int J Cardiol</source> <year>2007</year>; <volume>116</volume>: <fpage>410</fpage>–<lpage>412</lpage>.</citation>
</ref>
<ref id="bibr7-0267659112460075">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Topaz</surname><given-names>O</given-names></name>
<name><surname>Vetrovec</surname><given-names>GW</given-names></name>
</person-group>. <article-title>Anomalous first septal perforator artery: anatomic-clinical correlates</article-title>. <source>Clin Anat</source> <year>1996</year>; <volume>9</volume>: <fpage>14</fpage>–<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr8-0267659112460075">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Agarwal</surname><given-names>S</given-names></name>
<name><surname>Tuzcu</surname><given-names>EM</given-names></name>
<name><surname>Desai</surname><given-names>MY</given-names></name>
<etal/></person-group>. <article-title>Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy</article-title>. <source>J Am Coll Cardiol</source> <year>2010</year>; <volume>55</volume>: <fpage>823</fpage>–<lpage>834</lpage></citation>
</ref>
<ref id="bibr9-0267659112460075">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Choi</surname><given-names>D</given-names></name>
<name><surname>Dardano</surname><given-names>J</given-names></name>
<name><surname>Naidu</surname><given-names>SS</given-names></name>
</person-group>. <article-title>Alcohol septal ablation through an anomalous right coronary septal perforator: first report and discussion</article-title>. <source>J Invasive Cardiol</source> <year>2009</year>; <volume>21</volume>: <fpage>e106</fpage>–<lpage>109</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>